Close Menu

NEW YORK (GenomeWeb) – ID Genomics said today that it has formed a national consortium of clinical partners with the objective of improving the speed and accuracy of infectious disease diagnostics and antibiotic treatment.

The firm will work with partners in the consortium to record genetic fingerprints of antibiotic strains isolated from patients with active infections, and to characterize the strains' antibiotic susceptibility.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.